INPLASY202360007

Risk of Interstitial Lung Disease With Use of Programmed Cell Death 1 Inhibitors versus Programmed Cell Death Ligand 1 Inhibitors In Breast Cancer: A meta-analysis and Cases description

Keywords: Programmed Cell Death 1 Inhibitor; Programmed Cell Death Ligand 1 Inhibitor; Interstitial lung disease; Breast cancer; Immune-related adverseevents.

Download PDF - 202360007

Review Status: Completed and published